BCG VACCINE for Transitional cell carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 23 adverse event reports in the FDA FAERS database where BCG VACCINE was used for Transitional cell carcinoma.
Most Reported Side Effects for BCG VACCINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disseminated bacillus calmette-guerin infection | 87 | 20.8% | 15 | 32 |
| Immune reconstitution inflammatory syndrome | 60 | 14.4% | 5 | 13 |
| Pyrexia | 39 | 9.3% | 5 | 18 |
| Drug ineffective | 35 | 8.4% | 15 | 21 |
| Off label use | 35 | 8.4% | 8 | 8 |
| Granuloma | 16 | 3.8% | 1 | 5 |
| Mycobacterial infection | 16 | 3.8% | 5 | 14 |
| Vaccination complication | 15 | 3.6% | 0 | 5 |
| Lymphadenopathy | 14 | 3.4% | 2 | 1 |
| Disease progression | 12 | 2.9% | 2 | 0 |
| Infection | 12 | 2.9% | 1 | 9 |
| Neutropenia | 12 | 2.9% | 1 | 1 |
| Skin lesion | 12 | 2.9% | 3 | 0 |
| Acute kidney injury | 11 | 2.6% | 1 | 3 |
| Bladder cancer | 11 | 2.6% | 0 | 2 |
Other Indications for BCG VACCINE
Bladder cancer (135)
Immunisation (98)
Bladder transitional cell carcinoma (49)
Product used for unknown indication (30)
Mantle cell lymphoma (9)
Prophylaxis (9)
Bladder neoplasm (7)
Other Drugs Used for Transitional cell carcinoma
PEMBROLIZUMAB (1,951)
ENFORTUMAB VEDOTIN-EJFV (1,179)
GEMCITABINE (825)
ATEZOLIZUMAB (788)
CISPLATIN (672)
ENFORTUMAB VEDOTIN (649)
NIVOLUMAB (595)
AVELUMAB (554)
CARBOPLATIN (493)
GEMCITABINE\GEMCITABINE (255)